Ikarian Capital’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,313
| Closed | -$2.48M | – | 95 |
|
|
2023
Q1 | $2.48M | Sell |
8,313
-7,312
| -47% | -$2.18M | 0.56% | 32 |
|
|
2022
Q4 | $5.37M | Buy |
+15,625
| New | +$5.37M | 1.3% | 17 |
|
|
2022
Q2 | – | Sell |
-339
| Closed | -$113K | – | 114 |
|
|
2022
Q1 | $113K | Buy |
339
+16
| +5% | +$5.33K | 0.01% | 138 |
|
|
2021
Q4 | $104K | Buy |
+323
| New | +$104K | 0.02% | 133 |
|
|
2021
Q2 | – | Sell |
-327
| Closed | -$226K | – | 174 |
|
|
2021
Q1 | $226K | Buy |
+327
| New | +$226K | 0.01% | 158 |
|
|
2020
Q4 | – | Sell |
-170
| Closed | -$117K | – | 152 |
|
|
2020
Q3 | $117K | Sell |
170
-16,631
| -99% | -$11.4M | 0.01% | 95 |
|
|
2020
Q2 | $14.3M | Sell |
16,801
-26,556
| -61% | -$22.5M | 1.13% | 5 |
|
|
2020
Q1 | $15.5M | Buy |
43,357
+33,459
| +338% | +$12M | 1.17% | 2 |
|
|
2019
Q4 | $2.31M | Buy |
+9,898
| New | +$2.31M | 0.37% | 18 |
|